$249 for CRN members / $399 for non-members
Navigate evolving GRAS regulations and legislation with expert insights, risk strategies, and practical compliance guidance.
GRAS oversight is entering a period of significant change. FDA is expected to propose updates to the federal GRAS framework, while Congress and several states are advancing legislation that could reshape how ingredients are evaluated, marketed, and regulated. These developments have the potential to affect ingredient innovation, product development, compliance strategies, and business operations across the dietary supplement industry.
This half-day virtual workshop will help attendees understand what is changing, why it matters, and how to prepare. Expert speakers will examine the evolving federal and state landscape, explain the practical implications for dietary supplement companies, and discuss potential outcomes under different policy scenarios. Participants will gain actionable insights into emerging requirements, identify key risks and opportunities, and develop strategies to navigate a rapidly changing regulatory environment. Whether you are responsible for regulatory, scientific, legal, or business decisions, this program will equip you to anticipate change and respond with confidence.
Hear from:
- Emma Bryan, Manager of Corporate and Government Affairs, Nestle
- Alex Eapen, Senior Director, R&D Scientific & Regulatory Affairs – North America, Cargill
- Claire Kruger, Managing Partner, Spherix
- Tony Pavel, Partner, Keller and Heckman LLP
$249 for CRN members / $399 for non-members
